Table 2.
CD3+, CD4+, and CD8+ TILs MHC Class I and Class II Categories in Primary and Recurrent Tumors
| Primary |
Recurrent |
Total |
Fisher’s Exact P (Kappa) | |
|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | |
| CD3 low | CD3 high | |||
| CD3 low | 10 (41.7) | 14 (58.3) | 24 (100) | .059 |
| CD3 high | 15 (20.5) | 58 (79.5) | 73 (100) | (0.196) |
| CD4 low | CD4 high | |||
| CD4 low | 10 (40.0) | 15 (60.0) | 25 (100) | .006 |
| CD4 high | 9 (12.0) | 66 (88.0) | 75 (100) | (0.192) |
| CD8 low | CD8 high | |||
| CD8 low | 10 (41.7) | 14 (58.3) | 24 (100) | .122 |
| CD8 high | 18 (24.3) | 56 (75.7) | 74 (100) | (0.092) |
| MHC1 low | MHC1 high | |||
| MHC1 low | 1 (20.0) | 4 (80.0) | 5 (100) | .262 |
| MHC1 high | 5 (5.1) | 94 (94.9) | 99 (100) | (0.137) |
| MHC2 low | MHC2 high | |||
| MHC2 low | 27 (65.9) | 14 (34.1) | 41 (100) | <.0001 |
| MHC2 high | 18 (29.5) | 43 (70.5) | 61 (100) | (0.358) |